Antimicrobial update: Daptomycin.
Oberholzer
Christopher M
CM
University of Rochester School of Medicine and Dentistry, NY, USA.
Caserta
Mary T
MT
D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D017576:Daptomycin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D006095:Gram-Positive Cocci / Q000187:drug effects*; D006801:Humans; D051379:Mice; D008826:Microbial Sensitivity Tests; D017192:Skin Diseases, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D018461:Soft Tissue Infections / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D017576:Daptomycin